(2-CHLOROPYRIDIN-4-YL)(1-ISOPROPYL-1H-PYRROLO[3,2-C]PYRIDIN-3-YL)METHANONE, 95.0%, 250mg

2,5-Difluoro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline, 98%, 250mg

2-(3,4-Difluoro-5-methoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

5-Acetyl-2-(3-aminophenoxy) pyridine, 95%, 1g

4,4,5,5-tetramethyl-2-(2-methyl-4-nitrophenyl)-1,3,2-dioxaborolane, 95.0%, 250mg

Methyl (Phenyl 5-Acetamido-4,7,8-tri-O-acetyl-9-azido-3,5,9-trideoxy-2-thio-D-glycero-beta-D-galacto-2-nonulopyranosid)onate>92.0%(HPLC)100mg

1-methyl-9-oxa-1-azaspiro[5.5]undecan-4-one, 95.0%, 250mg

1-[4-(3-methoxyphenyl)-1h-imidazol-2-yl]ethan-1-amine dihydrochloride, 95%, 25g

5-Bromo-6-chloropicolinaldehyde, 95.0%, 250mg

HPLC column NUCLEODUR® NH2-RP 5 µm, 250 mm, 4.6 mm, 1 Piece(s)

5-Bromo-1H-imidazo[4,5-b]pyridine, 95.0%, 10g

DL-Meta-Tyrosine, >98%, 10g

Tetrasodium 1,1,2,2-Ethanetetracarboxylate, 97.0%, 1g